• -
715 Results
Capitol flag
The House’s Tax Relief Plan Is a Lesson in Poorly Designed Fiscal Policy
The House recently passed the Tax Relief for American Families and Workers Act (TRAFWA) of 2024, which aims to provide tax relief to businesses and families with children in a fiscally responsible manner. But, as fellow John W. Diamond’s new commentary explains, if the bill succeeds, it would instead deliver more reckless tax giveaways while further delaying a real effort to deal with the consequences of poor fiscal policy.
John W. Diamond March 8, 2024
kid riding bike
Children Walking and Biking: Mapping Houston’s Injury Hotspots
The number of children walking and biking to school has been in decline for more than 50 years, yet associated death and injury rates remain high. In a new brief, nonresident fellow Zoabe Hafeez and co-author Shruti Natarajan review child pedestrian and bicyclist injuries in Houston, analyzing the worst hotspots and identifying how infrastructure improvements can have outsized benefits.
Zoabe Hafeez, Shruti Natarajan March 5, 2024
Woman at refugee camp in Syria
Refugee Legal Protection and Capacity Building in Türkiye: A Conversation with Zaid Hydari
Turkey currently hosts nearly 4 million refugees — predominantly Syrians who have fled their country’s civil war. Ensuring adequate legal protection for those seeking asylum and improving the capacity of Turkish institutions and civil society organizations to serve those in need is vital. This policy brief, based on a conversation with Refugee Solidarity Network founder and director Zaid Hydari, explains how domestic and international bodies can support the many refugees in Turkey.
Kelsey Norman, Ana Martín Gil, Beyza Yildirim, Imogen Brown February 27, 2024
Seeds and flower of marijuana with gavel
Baker Briefing: Future of Federal Cannabis Reform
Over half of all Americans live in a state where cannabis is legalized. And yet, the federal government has not reclassified marijuana since 1970. According to the Controlled Substances Act, it is considered a “Schedule 1” substance — the same classification as heroin and crack cocaine with no accepted medical use.
Victoria Jupp, Gary J. Hale, Lisa Pittman February 9, 2024